Nvidia rarely has its target price lowered; this year's US stock market volatility has intensified
I'm LongbridgeAI, I can summarize articles.About Nvidia's Rare Target Price Downgrade
HSBC: Downgraded the target price from $195 per share to $185 per share (based on a 32 times PE valuation), and also lowered Nvidia's earnings per share forecast for the fiscal year 2026 by 6%.
Reason: It is expected that Nvidia's GB200 supply chain issues will continue into the first half of the fiscal year 2026 (from February 2025 to July 2025), resulting in limited "upside" growth potential for Nvidia in the first half, and greater pressure in the second half (from August 2025 to January 2026).
It is believed that the supply chain issues for GB200 still exist, especially in ODM assembly. HSBC also added that it is currently difficult to pinpoint the specific location of the GB200 supply chain issues, particularly as Nvidia's GB200 rack server architecture becomes increasingly complex. Previously, HSBC had also expressed concerns about issues such as copper connection modules from Amphenol, but these problems are expected to be resolved before the first quarter of the fiscal year 2026.
About Volatility
Nvidia experienced a significant fluctuation within 6 trading days, first surging by 10% and then dropping by 10%, indicating very high volatility. Specifically, the surge was driven by speculation around CES expectations, while the drop was due to CES not meeting expectations.
However, the root cause is the increased volatility in the broader market, namely the heightened volatility in U.S. stocks, which superficially appears to be due to the pause in interest rate cuts caused by inflation, but in reality, it is due to the excessive gains in U.S. stocks and high valuations. With U.S. stocks at historical highs and interest rates close to 5%, how can there not be volatility?
25-Year Investment Strategy Outlook: Embrace High Volatility!
As I mentioned before, volatility will increase in 2025, making short-term operations on heavyweight stocks more challenging. It is recommended to buy low and sell high; chasing high prices will be difficult in 2025, while bottom-fishing strategies may be more effective
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Author's posts
View moreAt the GTC conference, why did Jensen Huang say that computing power demand will increase 100 times!?
The market didn't buy Jensen Huang's story last night? The market showed no mercy as NVIDIA's stock price still plummeted. Even more embarrassing, NVIDIA's overnight drop happened right after Jensen Huang began his keynote speech. I think the main reasons are: first, the overall market was weak with the Nasdaq down nearly 2%; second, NVIDIA had already rebounded over 10 points, so the GTC positive news was already priced in; third, the market is too short-term focused and failed to recognize that this Show should be viewed from the perspective of long-term AI development...
2 likes · 1 repliesNVIDIA Recent Analysis: Deepseek, Capital Expenditure Review of Major Companies' Financial Reports, AI Application Targets
Analysis of the capital expenditures of major companies: Last year, Goldman Sachs made predictions in May and October regarding the capital expenditures of major giants such as Microsoft, Google, Meta, and Amazon (all major clients of Nvidia). The two forecasts estimated growth of 14% and 15% respectively by 2025. At the end of October and the beginning of November, several major companies announced their financial reports, indicating an upward adjustment in capital expenditures. So what is the real situation? Recently, Microsoft, Google, Amazon, and Meta all released their financial reports. Alphabet announced on Tuesday that its capital expenditure plan for this year is $75 billion...
1 repliesWSB Hot Discussion | SANA Soars 160.6%, QUBT Plummets 43.3%
Sana Biotechnology, Inc. SANA (SANA) 24-hour price change: 160.6% (small-cap pharmaceutical stock, generally not participating) Sana Biotechnology (stock code: SANA) has recently seen a strong surge in its stock price, mainly due to breakthrough progress in its diabetes research, coupled with a dual benefit from TD Cowen raising its rating. The market generally views the company's "hardcore" strength in the field of cell engineering therapy positively, especially its innovative breakthroughs in "bottleneck" medical challenges such as hematological malignancies and diabetes. Analysts believe...
